Quantum BioPharma Ltd.

NASDAQ: QNTM · Real-Time Price · USD
18.14
0.11 (0.61%)
At close: Aug 20, 2025, 3:59 PM

Quantum BioPharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 129.3K 112.8K 120.81K 136.78K 119.6K 125.59K 144.94K 1.12M 1.13M 1.16M 1.08M 1.12M 1.11M 1.1M 997.83K 974.02K 958.12K
Gross Profit
n/a -129.3K -112.8K -120.81K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-4.85M -3.38M -6.24M -4.18M -3.46M -2.26M -1.8M -2.76M -8.83M -9.37M -6.66M -7.25M -7.87M -5.65M -6.11M -5.13M -12.69M -9.8M
Interest Income
90.73K 67.01K 132.07K 163.87K 104.42K 172.52K 153.79K 174.07K 186.16K 272.34K 300.02K 65.5K 2.22K n/a n/a n/a n/a n/a
Pretax Income
-9.77M -8.71M -5.46M -4.02M -3.35M -2.09M -1.65M -1.13M -5.49M -9.96M -6.15M -7.13M -7.97M -5.46M -6.16M -5.61M -12.75M -9.41M
Net Income
-9.25M -8.55M -5.36M -3.83M -3.11M -1.9M -1.32M -1.06M -5.49M -9.96M -6.15M -7.13M -4.42M -5.91M -6.35M -5.79M -13.21M -9.94M
Selling & General & Admin
4.22M 1.6M 1.69M 3.21M 2.44M 1.97M 1.81M 2.69M 2.74M 5.86M 2.81M 4.24M 4.83M 3.86M 4.16M 4.24M 8.09M 6.88M
Research & Development
549.2K 1.64M 4.28M 744.8K 897.8K 160.26K -30.79K -32.98K 1.63M 2.31M 2.69M 1.76M 1.4M 937.05K 849.52K -106.53K 3.58M 1.97M
Other Expenses
81.03K n/a n/a n/a 122.53K n/a 21.98K 658.92K 4.48M 1.68M 1.16M 1.15M 1.63M 851.66K n/a 1M n/a 951.02K
Operating Expenses
4.85M 3.25M 5.97M 3.95M 3.46M 2.12M 1.8M 3.31M 8.83M 8.24M 5.64M 7.25M 7.87M 5.65M 5.01M 5.13M 11.74M 9.8M
Interest Expense
235.57K 349.56K 16.43K 10.37K 8.36K 12.41K 12.00 n/a n/a 667.00 135.00 16.05K 16.25K 16.38K 29.2K 1.96K 18.92K 19.32K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.85M 3.39M 5.99M 4.07M 3.46M 2.26M 1.8M 3.31M 8.83M 9.84M 6.66M 7.25M 7.87M 5.65M 6.12M 5.13M 12.69M 9.8M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
3.02M 1.14M 1.03M 917.85K 641.16K 610.03K 606.01K 602.96K 603.6K 599.42K 597.65K 587.78K 591.99K 615.37K 576.49K 558.4K 553.72K 413.83K
Shares Outstanding (Diluted)
3.02M 1.14M 1.03M 917.85K 641.16K 610.03K 606.01K 602.96K 603.6K 599.42K 597.65K 587.78K 591.99K 615.37K 576.49K 558.4K 553.72K 413.83K
EPS (Basic)
-3.23 -7.52 -5.22 -4.17 -4.85 -3.12 -2.18 -1.76 -9.1 -16.61 -10.29 -12.13 -7.47 -9.6 -11.01 -10.37 -23.85 -24.02
EPS (Diluted)
-3.23 -7.52 -5.22 -4.17 -4.85 -3.12 -2.18 -1.76 -9.1 -16.61 -10.29 -12.13 -7.47 -9.6 -11.01 -10.37 -23.85 -24.02
EBITDA
-9.39M -8.23M -5.33M -3.88M -3.21M -1.95M -1.53M -2.65M -4.38M -8.83M -5M -5.97M -6.82M -4.34M -5.03M -4.61M -11.75M -8.5M
EBIT
-9.53M -8.36M -5.44M -4M -3.34M -2.08M -1.65M -2.8M -5.49M -9.96M -6.15M -7.11M -7.95M -5.44M -6.13M -5.61M -12.74M -9.39M
Depreciation & Amortization
141.38K 129.3K 112.8K 121.78K 136.81K 120.14K 125.59K 146.81K 1.11M 1.13M 1.16M 1.15M 1.13M 1.1M 1.11M 1M 982.35K 951.02K